4Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distri- bution in invasive cervical cancer and high-grade cervical lesions : a meta-analysis update[J]. Int J Cancer,2007,21 ( 3 ) :621.
5McLaughlin-Drubin ME, Munger K. The human papillomavirus E7 on- eoprotein [J]. Virology,2009,384 (2) :335.
6Castellsagu6 X. Natural history and epidemiology of HPV infection and cervical cancer[J]. Gynecologic Oncolog,2008,110 ( 3 ) : S4.
7Villota C, Campos A, Vidaurre S, et al. Expression of mitochondrial ncRNAs is modulated by high risk HPV oncogenes [J]. J Biol Chem, 2012,287 (25) :21303.
8Oh Jung-Min, Kim Su Hyeong, Cho Eun-Ah, et al. Human papilloma- virus type 16 E5 protein inhibits hydrogen "peroxide-induced apoptosis by stimulating ubiquitin-proteasome- mediated degradation of Bax in human cervical cancer cells [J]. Carcinogenesis, 2010,31 ( 3 ) : 402.
9T Ristriani, S Fournane, G Orfanoudakis, et al. Masson. A single-co- don mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor,which induces p53-dependent senescence of HPV-positiveHeLa cervical cancer cells[ J]. Oncogene ,2009,28 ( 5 ) :762.
10P Massimi, A Shai, P Lambert, et al. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background[J]. Onco- gene,2008,27 (12) : 1800.
